6533b82cfe1ef96bd128feb6

RESEARCH PRODUCT

The role of panitumumab in combination with ECX in perioperative chemotherapy of unselected patients with locally advanced gastroesophageal adenocarcinomas: Randomized phase II study of the German Cancer Society.

Markus MoehlerStefan Paul MoenigThomas HoehlerMichael StahlAndré L. MihaljevicStephan KanzlerVolker KunzmannHansjochen WilkeAndreas SandermannAndrea TannapfelSebastian SchrollPeter C. Thuss-patienceFlorian LordickChristoph SchumacherHans-joachim Meyer

subject

OncologyCancer Researchmedicine.medical_specialtybusiness.industryLocally advancedPhases of clinical researchImproved survivalCancermacromolecular substancesmedicine.diseaseSurgerycarbohydrates (lipids)stomatognathic diseasesOncologyInternal medicinePerioperative chemotherapyotorhinolaryngologic diseasesmedicinebacteriaPanitumumabAdenocarcinomabusinessmedicine.drug

description

4040 Background: Perioperative chemotherapy (pCT) significantly improved survival of patients (pts) with locally advanced esophagogastric adenocarcinoma (la EGC). However, ~60% of pts will later di...

https://doi.org/10.1200/jco.2015.33.15_suppl.4040